Related Experiment Video
Updated: Feb 13, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Berberine regulates the microRNA-21-ITGΒ4-PDCD4 axis and inhibits colon cancer viability
Yanfeng Lü1, Bingbing Han2, Hualong Yu1
1Department of Anoproctology, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China.
Abstract:
Berberine is sourced from multiple medicinal herb resources and is easy to extract. With the advantages of low price, safety and convenience, berberine may have potential for wide clinical use. The present study aimed to investigate whether berberine inhibited the viability of colon cancer and whether it regulated the three-gene network microRNA (miR)-21-integrin β4 (ITGβ4)-programmed cell death 4 (PDCD4). It was demonstrated that berberine treatment suppressed colon cancer cell viability, and induced apoptosis and activated caspase-3 activity in the human colon carcinoma HCT116 cell line. Berberine inhibited miR-21 expression and promoted ITGβ4 and PDCD4 protein expression in the HCT116 cell line. Overexpression of miR-21 reduced the anti-cancer effects of berberine on cell viability, apoptosis rate and caspase-3 activity of the HCT116 cell line. However, it was revealed that the overexpression of miR-21 also suppressed ITGβ4 and PDCD4 protein expression in the HCT116 cell line. In conclusion, miR-21, ITGβ4 and PDCD4 are involved in the anti-cancer effects of berberine on cell viability and apoptosis in the HCT116 cell line.
Insights
Berberine suppresses colon cancer cell viability by inhibiting microRNA-21 (miR-21) and promoting integrin β4 (ITGβ4) and programmed cell death 4 (PDCD4) expression. This natural compound shows promise for clinical applications in colon cancer treatment.
Area of Science:
- Pharmacology
- Molecular Biology
- Oncology
Background:
- Berberine, a natural compound from medicinal herbs, is affordable, safe, and convenient, suggesting broad clinical potential.
- Colon cancer remains a significant health concern, necessitating novel therapeutic strategies.
- Understanding the molecular mechanisms underlying berberine's anti-cancer effects is crucial for its clinical application.
Purpose of the Study:
- To investigate the inhibitory effect of berberine on colon cancer cell viability.
- To elucidate the role of berberine in regulating the microRNA-21 (miR-21)-integrin β4 (ITGβ4)-programmed cell death 4 (PDCD4) gene network in colon cancer.
Main Methods:
- Utilized the human colon carcinoma HCT116 cell line for in vitro experiments.
- Assessed cell viability, apoptosis, and caspase-3 activity following berberine treatment.
- Quantified the expression levels of miR-21, ITGβ4, and PDCD4 proteins.
Main Results:
- Berberine treatment significantly suppressed colon cancer cell viability, induced apoptosis, and activated caspase-3.
- Berberine inhibited miR-21 expression while promoting ITGβ4 and PDCD4 protein expression in HCT116 cells.
- Overexpression of miR-21 counteracted berberine's anti-cancer effects and suppressed ITGβ4 and PDCD4 expression.
Conclusions:
- The miR-21/ITGβ4/PDCD4 network is implicated in the anti-cancer effects of berberine on colon cancer cell viability and apoptosis.
- Berberine demonstrates potential as a therapeutic agent for colon cancer through modulation of this specific molecular pathway.
Related Concept Videos
MicroRNAs
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Hormonal Regulation
Feedback Inhibition
Hypothalamic-Pituitary Axis

